PXD030905
PXD030905 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Proteome profile dataset of IDA treatment |
| Description | To study the mechanism underlying IDA-induced anti-tumor activity for Abi resistance, LNCaP-Abi cells were treated with Abi alone and in combination with IDA for 24 h. Protein profiles were determined by mass spectrometry |
| HostingRepository | iProX |
| AnnounceDate | 2022-01-12 |
| AnnouncementXML | Submission_2024-02-26_19:44:05.364.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Changlin Li |
| SpeciesList | scientific name: Homo sapiens; NCBI TaxID: 9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Q Exactive Plus |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2022-01-12 00:29:38 | ID requested | |
| 1 | 2024-01-02 19:59:00 | announced | |
| ⏵ 2 | 2024-02-26 19:44:06 | announced | 2024-02-27: Update information. |
Publication List
| Zhang Y, Wei W, Li C, Yan S, Wang S, Xiao S, He C, Li J, Qi Z, Li B, Yang K, Li C, Idarubicin combats abiraterone and enzalutamide resistance in prostate cells via targeting XPA protein. Cell Death Dis, 13(12):1034(2022) [pubmed] |
Keyword List
| submitter keyword: IDA |
Contact List
| Changlin Li | |
|---|---|
| contact affiliation | Jining Medical University |
| contact email | changlinli@mail.nankai.edu.cn |
| lab head | |
| Changlin Li | |
| contact affiliation | Jining Medical University |
| contact email | changlinli@mail.nankai.edu.cn |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |
to receive all new ProteomeXchange dataset release announcements!
